Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |